Literature DB >> 24033876

Serum Helicobacter pylori CagA antibody titer as a useful marker for advanced inflammation in the stomach in Japan.

Seiji Shiota1, Kazunari Murakami, Tadayoshi Okimoto, Masaaki Kodama, Yoshio Yamaoka.   

Abstract

BACKGROUND AND AIM: Subjects infected with Helicobacter pylori containing cagA do not always induce serum CagA antibody. Our previous meta-analysis showed that serum CagA seropositivity was associated with gastric cancer even in East Asian countries. However, it remains unclear why serum CagA-positive status is associated with gastric cancer. In this study, we aimed to examine the relationship between anti-CagA antibody titer and the levels of pepsinogen (PG), and histological score.
METHODS: Eighty-eight H. pylori-positive Japanese patients with gastritis were included. Serum CagA antibody titer, PG I, and PG II were evaluated by ELISA. Histological scores were evaluated according to Update Sydney System. CagA expression was examined by immunoblot.
RESULTS: Seroprevalence of CagA antibody was found in 75.0%. Interestingly, serum CagA antibody titer was significantly correlated with PG I and PG II levels (P = 0.003 and 0.004, respectively). Serum CagA antibody titer was also significantly correlated with mucosal inflammation in the corpus (P = 0.04). On the other hand, bacterial density was not related with CagA antibody titer. CagA expression level of the strains was irrespective of the status of PG and serum CagA antibody.
CONCLUSIONS: Subjects with higher serum CagA antibody titer can be considered as high-risk population for the development of gastric cancer from the point of strong gastric inflammatory response even in Japan. Host recognition rather than bacterial colonization might be associated with the difference of serum CagA antibody titer.
© 2013 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  CagA; Helicobacter pylori; pepsinogen; serum antibody

Mesh:

Substances:

Year:  2014        PMID: 24033876      PMCID: PMC3870047          DOI: 10.1111/jgh.12359

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  55 in total

1.  Antibody against Helicobacter pylori CagA and VacA and the risk for gastric cancer.

Authors:  Y Yamaoka; T Kodama; K Kashima; D Y Graham
Journal:  J Clin Pathol       Date:  1999-03       Impact factor: 3.411

2.  Allelic variation in the cagA gene of Helicobacter pylori obtained from Korea compared to the United States.

Authors:  S Miehlke; K Kibler; J G Kim; N Figura; S M Small; D Y Graham; M F Go
Journal:  Am J Gastroenterol       Date:  1996-07       Impact factor: 10.864

3.  Molecular epidemiology of Helicobacter pylori: separation of H. pylori from East Asian and non-Asian countries.

Authors:  Y Yamaoka; M S Osato; A R Sepulveda; O Gutierrez; N Figura; J G Kim; T Kodama; K Kashima; D Y Graham
Journal:  Epidemiol Infect       Date:  2000-02       Impact factor: 2.451

Review 4.  Helicobacter pylori and gastric cancer: factors that modulate disease risk.

Authors:  Lydia E Wroblewski; Richard M Peek; Keith T Wilson
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

5.  Mutagenic potency of Helicobacter pylori in the gastric mucosa of mice is determined by sex and duration of infection.

Authors:  Alexander Sheh; Chung Wei Lee; Kenichi Masumura; Barry H Rickman; Takehiko Nohmi; Gerald N Wogan; James G Fox; David B Schauer
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-10       Impact factor: 11.205

6.  Helicobacter pylori and atrophic gastritis: importance of the cagA status.

Authors:  E J Kuipers; G I Pérez-Pérez; S G Meuwissen; M J Blaser
Journal:  J Natl Cancer Inst       Date:  1995-12-06       Impact factor: 13.506

Review 7.  The connection between C-reactive protein and atherosclerosis.

Authors:  Sanjay K Singh; Madathilparambil V Suresh; Bhavya Voleti; Alok Agrawal
Journal:  Ann Med       Date:  2008       Impact factor: 4.709

Review 8.  Role of type IV secretion in Helicobacter pylori pathogenesis.

Authors:  Steffen Backert; Matthias Selbach
Journal:  Cell Microbiol       Date:  2008-04-08       Impact factor: 3.715

9.  CagA seropositivity associated with development of gastric cancer in a Japanese population.

Authors:  T Shimoyama; S Fukuda; M Tanaka; T Mikami; A Munakata; J E Crabtree
Journal:  J Clin Pathol       Date:  1998-03       Impact factor: 3.411

10.  Molecular epidemiology and outcome of Helicobacter pylori infection in Thailand: a cultural cross roads.

Authors:  Ratha-Korn Vilaichone; Varocha Mahachai; Somying Tumwasorn; Jeng-Yih Wu; David Y Graham; Yoshio Yamaoka
Journal:  Helicobacter       Date:  2004-10       Impact factor: 5.753

View more
  12 in total

Review 1.  Biomarkers for Helicobacter pylori infection and gastroduodenal diseases.

Authors:  Seiji Shiota; Yoshio Yamaoka
Journal:  Biomark Med       Date:  2014       Impact factor: 2.851

2.  Epitope peptides of Helicobacter pylori CagA antibodies from sera by whole-peptide mapping.

Authors:  Shamshul Ansari; Junko Akada; Yuichi Matsuo; Seiji Shiota; Yoko Kudo; Tadayoshi Okimoto; Kazunari Murakami; Yoshio Yamaoka
Journal:  J Gastroenterol       Date:  2019-05-02       Impact factor: 7.527

3.  Does the antibody production ability affect the serum anti-Helicobacter pylori IgG titer?

Authors:  Hyun Ah Chung; Sun-Young Lee; Hee Won Moon; Jeong Hwan Kim; In-Kyung Sung; Hyung Seok Park; Chan Sup Shim; Hye Seung Han
Journal:  World J Gastrointest Pathophysiol       Date:  2016-08-15

4.  Characterization of a novel Helicobacter pylori East Asian-type CagA ELISA for detecting patients infected with various cagA genotypes.

Authors:  Dalla Doohan; Muhammad Miftahussurur; Yuichi Matsuo; Yasutoshi Kido; Junko Akada; Takeshi Matsuhisa; Than Than Yee; Kyaw Htet; Hafeza Aftab; Ratha-Korn Vilaichone; Varocha Mahachai; Thawee Ratanachu-Ek; Lotay Tshering; Langgeng Agung Waskito; Kartika Afrida Fauzia; Tomohisa Uchida; Ari Fahrial Syam; Yudith Annisa Ayu Rezkitha; Yoshio Yamaoka
Journal:  Med Microbiol Immunol       Date:  2019-09-23       Impact factor: 3.402

5.  Differences in antibody levels to H. pylori virulence factors VacA and CagA among African Americans and whites in the Southeast USA.

Authors:  Julia Butt; William J Blot; Martha J Shrubsole; Tim Waterboer; Michael Pawlita; Meira Epplein
Journal:  Cancer Causes Control       Date:  2020-03-28       Impact factor: 2.506

6.  Flavonoid Glycosides of Polygonum capitatum Protect against Inflammation Associated with Helicobacter pylori Infection.

Authors:  Shu Zhang; Fei Mo; Zhaoxun Luo; Jian Huang; Chaoqin Sun; Ran Zhang
Journal:  PLoS One       Date:  2015-05-18       Impact factor: 3.240

7.  Immunopathological and Modulatory Effects of Cag A+ Genotype on Gastric Mucosa, Inflammatory Response, Pepsinogens, and Gastrin-17 Secretion in Iraqi Patients infected with H. pylori.

Authors:  Ali Ibrahim Ali Al-Ezzy
Journal:  Open Access Maced J Med Sci       Date:  2018-05-14

8.  Association of helicobacter pylori infection and chronic atrophic gastritis with risk of colonic, pancreatic and gastric cancer: A ten-year follow-up of the ESTHER cohort study.

Authors:  Xin-Zu Chen; Ben Schöttker; Felipe Andres Castro; Hongda Chen; Yan Zhang; Bernd Holleczek; Hermann Brenner
Journal:  Oncotarget       Date:  2016-03-29

9.  Assessment of Risk and Sero-Prevalence of Helicobacter pylori Colonization among Remote Orang Asli Tribes in Peninsula Malaysia.

Authors:  Kavitha Thevakumar; Josephine Rebecca Chandren; Guillermo Ignacio Perez-Perez; Eng Guan Chua; Lay Kek Teh; Mohd Zaki Salleh; Jin Ai Mary Anne Tan; Alex Hwong Ruey Leow; Khean Lee Goh; Alfred Chin Yen Tay; Barry J Marshall; Jamuna Vadivelu; Mun Fai Loke; Li Ping Wong
Journal:  PLoS One       Date:  2016-07-21       Impact factor: 3.240

Review 10.  Helicobacter pylori Antibody Titer and Gastric Cancer Screening.

Authors:  Hiroshi Kishikawa; Kayoko Kimura; Sakiko Takarabe; Shogo Kaida; Jiro Nishida
Journal:  Dis Markers       Date:  2015-09-30       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.